首页 > 最新文献

ACS Synthetic Biology最新文献

英文 中文
Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity – Author’s reply 糖代谢异常和肝脏脂质含量影响肥胖症患者胰岛素抵抗与肝脏线粒体功能之间的联系 - 作者回复
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.11.003
Sabine Kahl, Michael Roden

Section snippets

Financial suppport

The research of the authors is supported in part by grants from the German Federal Ministry of Health (BMG), the Ministry of Culture and Science of the State North Rhine Westphalia (MKW NRW) to DDZ, and the German Federal Ministry of Education and Research (BMBF) and the MKW NRW to German Center for Diabetes Research (DZD e. V.). The research of M.R. is supported by grants from the European Community (HORIZON-HLTH-2022-STAYHLTH-02-01: Panel A) to the INTERCEPT-T2D consortium, the German Science

Author contributions

S.K. drafted the manuscript. S.K. and M.R. revised and approve the final version of the manuscript. M.R. is the guarantor of this work, with full access to all data and analyses related to the content of this article.

ClinTrials.gov identifier

NCT01477957We thank Xiyin Yang and Qiang Hu for their interest in our article [1], which investigated the association of whole-body insulin sensitivity and hepatic OXPHOS capacity in people with obesity grade 3. We would like to take the opportunity to address their comments on our study.First, the prospective BARIA-DDZ study was designed to assess metabolic changes with one focus on different features of hepatic mitochondrial function in people with obesity. For this purpose, we developed a

Declaration of Competing Interest

M.R. received lecture fees or served on advisory boards for AstraZeneca, Echosens, Eli Lilly, Madrigal, Merck-MSD, Novo Nordisk and Target RWE and performed investigator-initiated research with support from Boehringer Ingelheim, Novo Nordisk and Nutricia/Danone to the German Diabetes Center (DDZ). No conflicts of interest, financial or otherwise, are declared by the other authors.
作者的研究部分得到了德国联邦卫生部(BMG)、北莱茵威斯特法伦州文化与科学部(MKW NRW)对DDZ的资助,以及德国联邦教育与研究部(BMBF)和北莱茵威斯特法伦州文化与科学部对德国糖尿病研究中心(DZD e. V.)的资助。M.R.的研究得到了欧洲共同体(HORIZON-HLTH-2022-STAYHLTH-02-01:A组)对INTERCEPT-T2D联盟、德国科学基金会的资助。S.K. 和 M.R. 修改并批准了手稿的最终版本。M.R.是这项工作的担保人,完全有权使用与本文内容相关的所有数据和分析。ClinTrials.gov identifierNCT01477957我们感谢杨希银和胡强对我们文章[1]的关注,我们的文章研究了肥胖3级患者全身胰岛素敏感性与肝脏OXPHOS能力的关系。首先,前瞻性 BARIA-DDZ 研究旨在评估肥胖症患者的代谢变化,重点是肝线粒体功能的不同特征。为此,我们制定了一项竞争利益声明。M.R.接受了阿斯利康、Echosens、礼来、Madrigal、默克-MSD、诺和诺德和 Target RWE 的讲课费或担任顾问委员会成员,并在勃林格殷格翰、诺和诺德和 Nutricia/Danone 对德国糖尿病中心 (DDZ) 的支持下开展了由研究者发起的研究。其他作者未声明有经济或其他方面的利益冲突。
{"title":"Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity – Author’s reply","authors":"Sabine Kahl, Michael Roden","doi":"10.1016/j.jhep.2024.11.003","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.11.003","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial suppport</h2>The research of the authors is supported in part by grants from the German Federal Ministry of Health (BMG), the Ministry of Culture and Science of the State North Rhine Westphalia (MKW NRW) to DDZ, and the German Federal Ministry of Education and Research (BMBF) and the MKW NRW to German Center for Diabetes Research (DZD e. V.). The research of M.R. is supported by grants from the European Community (HORIZON-HLTH-2022-STAYHLTH-02-01: Panel A) to the INTERCEPT-T2D consortium, the German Science</section></section><section><section><h2>Author contributions</h2>S.K. drafted the manuscript. S.K. and M.R. revised and approve the final version of the manuscript. M.R. is the guarantor of this work, with full access to all data and analyses related to the content of this article.</section></section><section><section><h2>ClinTrials.gov identifier</h2>NCT01477957We thank Xiyin Yang and Qiang Hu for their interest in our article [1], which investigated the association of whole-body insulin sensitivity and hepatic OXPHOS capacity in people with obesity grade 3. We would like to take the opportunity to address their comments on our study.First, the prospective BARIA-DDZ study was designed to assess metabolic changes with one focus on different features of hepatic mitochondrial function in people with obesity. For this purpose, we developed a</section></section><section><section><h2>Declaration of Competing Interest</h2>M.R. received lecture fees or served on advisory boards for AstraZeneca, Echosens, Eli Lilly, Madrigal, Merck-MSD, Novo Nordisk and Target RWE and performed investigator-initiated research with support from Boehringer Ingelheim, Novo Nordisk and Nutricia/Danone to the German Diabetes Center (DDZ). No conflicts of interest, financial or otherwise, are declared by the other authors.</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"18 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142596804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic plasma exchange in acute liver failure: Challenges in patient selection and optimal timing of intervention 急性肝衰竭的治疗性血浆置换:患者选择和最佳干预时机的挑战
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.10.036
Bikrant Bihari Lal, Seema Alam

Section snippets

Author’s contribution

BBL prepared the first draft. SA critically reviewed and approved the final manuscript.

Financial disclosure

None

Declaration of Competing Interest

Bikrant Bihari Lal and Seema Alam declare no financial or non-financial conflict of interest.
章节片段作者贡献BBL 撰写了初稿,SA 严格审阅并批准了最终稿。财务披露无竞争利益声明比克兰特-比哈里-拉尔和西玛-阿拉姆声明没有财务或非财务利益冲突。
{"title":"Therapeutic plasma exchange in acute liver failure: Challenges in patient selection and optimal timing of intervention","authors":"Bikrant Bihari Lal, Seema Alam","doi":"10.1016/j.jhep.2024.10.036","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.036","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Author’s contribution</h2>BBL prepared the first draft. SA critically reviewed and approved the final manuscript.</section></section><section><section><h2>Financial disclosure</h2>None</section></section><section><section><h2>Declaration of Competing Interest</h2>Bikrant Bihari Lal and Seema Alam declare no financial or non-financial conflict of interest.</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"16 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A stealthy neural recorder for the study of behaviour in primates 用于灵长类动物行为研究的隐形神经记录器
IF 28.1 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-08 DOI: 10.1038/s41551-024-01280-w
Saehyuck Oh, Janghwan Jekal, Jinyoung Won, Kyung Seob Lim, Chang-Yeop Jeon, Junghyung Park, Hyeon-Gu Yeo, Yu Gyeong Kim, Young Hee Lee, Leslie Jaesun Ha, Han Hee Jung, Junwoo Yea, Hyeokjun Lee, Jeongdae Ha, Jinmo Kim, Doyoung Lee, Soojeong Song, Jieun Son, Tae Sang Yu, Jungmin Lee, Sanghoon Lee, Jaehong Lee, Bong Hoon Kim, Ji-Woong Choi, Jong-Cheol Rah, Young Min Song, Jae-Woong Jeong, Hyung Jin Choi, Sheng Xu, Youngjeon Lee, Kyung-In Jang

By monitoring brain neural signals, neural recorders allow for the study of neurological mechanisms underlying specific behavioural and cognitive states. However, the large brain volumes of non-human primates and their extensive range of uncontrolled movements and inherent wildness make it difficult to carry out covert and long-term recording and analysis of deep-brain neural signals. Here we report the development and performance of a stealthy neural recorder for the study of naturalistic behaviours in non-human primates. The neural recorder includes a fully implantable wireless and battery-free module for the recording of local field potentials and accelerometry data in real time, a flexible 32-electrode neural probe with a resorbable insertion shuttle, and a repeater coil-based wireless-power-transfer system operating at the body scale. We used the device to record neurobehavioural data for over 1 month in a freely moving monkey and leveraged the recorded data to train an artificial intelligence model for the classification of the animals’ eating behaviours.

通过监测脑神经信号,神经记录器可以研究特定行为和认知状态的神经机制。然而,非人灵长类动物的脑容量大,不受控制的运动范围广,且具有与生俱来的野性,因此很难对深层脑神经信号进行隐蔽、长期的记录和分析。在此,我们报告了用于研究非人灵长类动物自然行为的隐蔽式神经记录器的开发和性能。该神经记录器包括一个用于实时记录局部场电位和加速度数据的完全可植入式无线无电池模块、一个带有可吸收插入梭的灵活的 32 个电极神经探针和一个基于中继线圈的体表无线功率传输系统。我们使用该装置记录了一只自由活动的猴子一个多月的神经行为数据,并利用记录的数据训练了一个人工智能模型,用于对动物的进食行为进行分类。
{"title":"A stealthy neural recorder for the study of behaviour in primates","authors":"Saehyuck Oh, Janghwan Jekal, Jinyoung Won, Kyung Seob Lim, Chang-Yeop Jeon, Junghyung Park, Hyeon-Gu Yeo, Yu Gyeong Kim, Young Hee Lee, Leslie Jaesun Ha, Han Hee Jung, Junwoo Yea, Hyeokjun Lee, Jeongdae Ha, Jinmo Kim, Doyoung Lee, Soojeong Song, Jieun Son, Tae Sang Yu, Jungmin Lee, Sanghoon Lee, Jaehong Lee, Bong Hoon Kim, Ji-Woong Choi, Jong-Cheol Rah, Young Min Song, Jae-Woong Jeong, Hyung Jin Choi, Sheng Xu, Youngjeon Lee, Kyung-In Jang","doi":"10.1038/s41551-024-01280-w","DOIUrl":"https://doi.org/10.1038/s41551-024-01280-w","url":null,"abstract":"<p>By monitoring brain neural signals, neural recorders allow for the study of neurological mechanisms underlying specific behavioural and cognitive states. However, the large brain volumes of non-human primates and their extensive range of uncontrolled movements and inherent wildness make it difficult to carry out covert and long-term recording and analysis of deep-brain neural signals. Here we report the development and performance of a stealthy neural recorder for the study of naturalistic behaviours in non-human primates. The neural recorder includes a fully implantable wireless and battery-free module for the recording of local field potentials and accelerometry data in real time, a flexible 32-electrode neural probe with a resorbable insertion shuttle, and a repeater coil-based wireless-power-transfer system operating at the body scale. We used the device to record neurobehavioural data for over 1 month in a freely moving monkey and leveraged the recorded data to train an artificial intelligence model for the classification of the animals’ eating behaviours.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"95 1","pages":""},"PeriodicalIF":28.1,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to “Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: a promising strategy?” and “Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B” 对 "免疫检查点抑制剂治疗癌症患者的乙型肝炎功能性治愈:一种前景广阔的策略?"和 "肝细胞癌患者是免疫检查点抑制剂治疗乙型肝炎的理想研究人群 "的回复
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.10.045
Hsien-Chen Mon, Yi-Hsiang Huang

Section snippets

Financial disclosure funding

No financial support was received for this letter.

Funding funding

None

Conflict-of-interest statement COI

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Author contributions author-disclosure

HCM: manuscript drafting; YHH: critical expert review and revision of the manuscript.

Acknowledgements

There are no additional acknowledgements.
章节片段财务披露资助本信件未收到任何财务支持。资助资助无利益冲突声明作者声明他们没有已知的竞争性财务利益或个人关系,这些利益或关系可能会影响本文所报告的工作。作者贡献作者披露HCM:手稿起草;YHH:关键专家评审和手稿修改。致谢无其他致谢。
{"title":"Reply to “Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: a promising strategy?” and “Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B”","authors":"Hsien-Chen Mon, Yi-Hsiang Huang","doi":"10.1016/j.jhep.2024.10.045","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.045","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial disclosure funding</h2>No financial support was received for this letter.</section></section><section><section><h2>Funding funding</h2>None</section></section><section><section><h2>Conflict-of-interest statement COI</h2>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</section></section><section><section><h2>Author contributions author-disclosure</h2>HCM: manuscript drafting; YHH: critical expert review and revision of the manuscript.</section></section><section><section><h2>Acknowledgements</h2>There are no additional acknowledgements.</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"29 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142596808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Reassessing the causal association between frailty and chronic liver disease: Evidence from genetic analyses” 答复"重新评估虚弱与慢性肝病之间的因果关系:来自基因分析的证据"
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-07 DOI: 10.1016/j.jhep.2024.10.034
Qi Zhong, Hao-Wen Chen, Shun Zhang, Ji-Yuan Zhou, Xian-Bo Wu

Section snippets

Data availability statement

GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (https://gwas.mrcieu.ac.uk/). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (https://r11.finngen.fi/).

Authors’ contributions

QZ, H-WC, and SZ drafted the manuscript and performed the main MR analyses. X-BW and J-YZ revised the manuscript. All authors reviewed and approved the final manuscript.

Financial support

This study was supported by the National Natural Science Foundation of China [grant numbers 82173607, 82173619], and the Guangdong Basic and Applied Basic Research Foundation [grant numbers 2021A1515011684, 2024A1515011969]. The funders had no role in study design, data collection or analysis, data interpretation, manuscript writing, or decision to submit the paper for publication.

Declaration of Competing Interest

The authors of this study declare that they do not have any conflict of interest.

Acknowledgements

GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (https://gwas.mrcieu.ac.uk/). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (https://r11.finngen.fi/).
章节片段数据提供声明虚弱的GWAS汇总统计数据可从MRC-EU GWAS数据库(https://gwas.mrcieu.ac.uk/)下载。同样,肝脏疾病的 GWAS 统计摘要也可通过 FinnGen 财团获取 (https://r11.finngen.fi/)。作者贡献QZ、H-WC 和 SZ 起草了稿件并进行了主要的 MR 分析。X-BW 和 J-YZ 修改了手稿。本研究得到了国家自然科学基金[基金号:82173607、82173619]和广东省基础与应用基础研究基金[基金号:2021A1515011684、2024A1515011969]的资助。资助者在研究设计、数据收集或分析、数据解释、稿件撰写以及决定是否将论文提交发表等方面均未发挥作用。利益冲突声明本研究的作者声明他们没有任何利益冲突。致谢虚弱的GWAS汇总统计数据可从MRC-IEU GWAS数据库(https://gwas.mrcieu.ac.uk/)下载。同样,肝病的 GWAS 统计摘要也可通过 FinnGen 财团 (https://r11.finngen.fi/) 访问。
{"title":"Reply to: “Reassessing the causal association between frailty and chronic liver disease: Evidence from genetic analyses”","authors":"Qi Zhong, Hao-Wen Chen, Shun Zhang, Ji-Yuan Zhou, Xian-Bo Wu","doi":"10.1016/j.jhep.2024.10.034","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.034","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Data availability statement</h2>GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (<span><span>https://gwas.mrcieu.ac.uk/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (<span><span>https://r11.finngen.fi/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</section></section><section><section><h2>Authors’ contributions</h2>QZ, H-WC, and SZ drafted the manuscript and performed the main MR analyses. X-BW and J-YZ revised the manuscript. All authors reviewed and approved the final manuscript.</section></section><section><section><h2>Financial support</h2>This study was supported by the National Natural Science Foundation of China [grant numbers 82173607, 82173619], and the Guangdong Basic and Applied Basic Research Foundation [grant numbers 2021A1515011684, 2024A1515011969]. The funders had no role in study design, data collection or analysis, data interpretation, manuscript writing, or decision to submit the paper for publication.</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors of this study declare that they do not have any conflict of interest.</section></section><section><section><h2>Acknowledgements</h2>GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (<span><span>https://gwas.mrcieu.ac.uk/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (<span><span>https://r11.finngen.fi/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"61 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to: “From mice to humans: Unravelling the genetic levers of NASH” [J Hepatol (2020) 749-751] 更正:"从小鼠到人类:揭示 NASH 的遗传杠杆" [J Hepatol (2020) 749-751] 更正
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-07 DOI: 10.1016/j.jhep.2024.10.002
Wajahat Zafar Mehal
It has come to our attention that the following text should have been included in the ‘Financial support’ section of this article: “Dr. Mehal has an appointment at the West Haven VA Medical Center and this work was supported by a US Department of Veterans Office of Research & Development with grant BX003259-05A1”. We apologise for any inconvenience caused.
我们注意到,本文的 "财务支持 "部分应包含以下文字:"Mehal 博士在西黑文退伍军人医疗中心(West Haven VA Medical Center)任职,这项工作得到了美国退伍军人部研究与发展办公室(US Department of Veterans Office of Research & Development)BX003259-05A1 号基金的支持。我们对由此造成的不便深表歉意。
{"title":"Corrigendum to: “From mice to humans: Unravelling the genetic levers of NASH” [J Hepatol (2020) 749-751]","authors":"Wajahat Zafar Mehal","doi":"10.1016/j.jhep.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.002","url":null,"abstract":"It has come to our attention that the following text should have been included in the ‘Financial support’ section of this article: “Dr. Mehal has an appointment at the West Haven VA Medical Center and this work was supported by a US Department of Veterans Office of Research &amp; Development with grant BX003259-05A1”. We apologise for any inconvenience caused.","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"37 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical Assessment of Protein Engineering (CAPE): A Student Challenge on the Cloud 蛋白质工程批判性评估 (CAPE):云上的学生挑战赛
IF 3.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-07 DOI: 10.1021/acssynbio.4c0058810.1021/acssynbio.4c00588
Lihao Fu, Yuan Gao, Yongcan Chen, Yanjing Wang, Xiaoting Fang, Shujun Tian, Hao Dong, Yijian Zhang, Zichuan Chen, Zechen Wang, Shantong Hu, Xiao Yi* and Tong Si*, 

The success of AlphaFold in protein structure prediction highlights the power of data-driven approaches in scientific research. However, developing machine learning models to design and engineer proteins with desirable functions is hampered by limited access to high-quality data sets and experimental feedback. The Critical Assessment of Protein Engineering (CAPE) challenge addresses these issues through a student-focused competition, utilizing cloud computing and biofoundries to lower barriers to entry. CAPE serves as an open platform for community learning, where mutant data sets and design algorithms from past contestants help improve overall performance in subsequent rounds. Through two competition rounds, student participants collectively designed >1500 new mutant sequences, with the best-performing variants exhibiting catalytic activity up to 5-fold higher than the wild-type parent. We envision CAPE as a collaborative platform to engage young researchers and promote computational protein engineering.

AlphaFold 在蛋白质结构预测方面的成功凸显了数据驱动方法在科学研究中的力量。然而,由于获得高质量数据集和实验反馈的途径有限,开发机器学习模型以设计和改造具有理想功能的蛋白质的工作受到了阻碍。蛋白质工程关键评估(CAPE)挑战赛通过以学生为中心的竞赛,利用云计算和生物设施降低准入门槛,解决了这些问题。CAPE 是一个开放的社区学习平台,来自往届参赛者的突变数据集和设计算法有助于提高后续比赛的整体表现。通过两轮比赛,学生参赛者共设计出 1500 个新的突变序列,其中表现最好的变体的催化活性比野生型亲本高出 5 倍。我们设想将 CAPE 作为一个合作平台,让年轻研究人员参与其中,促进计算蛋白质工程的发展。
{"title":"Critical Assessment of Protein Engineering (CAPE): A Student Challenge on the Cloud","authors":"Lihao Fu,&nbsp;Yuan Gao,&nbsp;Yongcan Chen,&nbsp;Yanjing Wang,&nbsp;Xiaoting Fang,&nbsp;Shujun Tian,&nbsp;Hao Dong,&nbsp;Yijian Zhang,&nbsp;Zichuan Chen,&nbsp;Zechen Wang,&nbsp;Shantong Hu,&nbsp;Xiao Yi* and Tong Si*,&nbsp;","doi":"10.1021/acssynbio.4c0058810.1021/acssynbio.4c00588","DOIUrl":"https://doi.org/10.1021/acssynbio.4c00588https://doi.org/10.1021/acssynbio.4c00588","url":null,"abstract":"<p >The success of AlphaFold in protein structure prediction highlights the power of data-driven approaches in scientific research. However, developing machine learning models to design and engineer proteins with desirable functions is hampered by limited access to high-quality data sets and experimental feedback. The Critical Assessment of Protein Engineering (CAPE) challenge addresses these issues through a student-focused competition, utilizing cloud computing and biofoundries to lower barriers to entry. CAPE serves as an open platform for community learning, where mutant data sets and design algorithms from past contestants help improve overall performance in subsequent rounds. Through two competition rounds, student participants collectively designed &gt;1500 new mutant sequences, with the best-performing variants exhibiting catalytic activity up to 5-fold higher than the wild-type parent. We envision CAPE as a collaborative platform to engage young researchers and promote computational protein engineering.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"13 11","pages":"3782–3787 3782–3787"},"PeriodicalIF":3.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acssynbio.4c00588","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Methodology and Data Integrity in Mendelian Randomization: Insights from Air Pollution and MASLD Research 反思孟德尔随机化的方法和数据完整性:空气污染和 MASLD 研究的启示
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.040
Junhao Chen, Haifeng Wang, Shi Fu

Section snippets

Authors’ contributions

Junhao Chen: conceptualization and manuscript draft. Haifeng Wang: supporting role in revision for important intellectual content. Shi Fu: critical revision for important intellectual content, final approval.

Financial support

None

Declaration of Competing Interest

The authors of this study declare that they do not have any conflict of interest.
章节片段作者贡献陈俊豪:构思和手稿起草。王海峰:对重要知识内容的修改起支持作用。财务支持无竞争利益声明本研究的作者声明他们没有任何利益冲突。
{"title":"Rethinking Methodology and Data Integrity in Mendelian Randomization: Insights from Air Pollution and MASLD Research","authors":"Junhao Chen, Haifeng Wang, Shi Fu","doi":"10.1016/j.jhep.2024.10.040","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.040","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors’ contributions</h2>Junhao Chen: conceptualization and manuscript draft. Haifeng Wang: supporting role in revision for important intellectual content. Shi Fu: critical revision for important intellectual content, final approval.</section></section><section><section><h2>Financial support</h2>None</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors of this study declare that they do not have any conflict of interest.</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"304 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy” 答复"恩替卡韦治疗停止后 HBsAg 消失的预测"
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.041
Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen

Section snippets

AUTHOR CONTRIBUTIONS

RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.

DISCLOSURES/ CONFLICT OF INTEREST STATEMENT

MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.

DATA AVAILABILITY STATEMENT

The data from this study is available from the corresponding author upon reasonable request.

Funding

Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.
章节片段作者贡献RWH Hui参与了手稿的设计和起草。LY Mak 参与了稿件的重要修改。MF Yuen 参与了稿件的关键修改和整个研究的监督。作者声明:他们参与了手稿的准备工作,并审阅和批准了最终版本。声明/利益冲突声明MF Yuen 是艾伯维、Arbutus Biopharma、Assembly Biosciences、Bristol Myer Squibb、Dicerna Pharmaceuticals、葛兰素史克、吉利德科学、杨森、默克夏普和多美、Clear B Therapeutics、Springbank Pharmaceuticals 的顾问委员会成员和/或接受其研究资助;并接受 Arrowhead Pharmaceuticals、Fujirebio Incorporation 和 Sysmex Corporation 的研究资助。其余作者无利益冲突。数据提供声明本研究的数据可向相应作者索取。资助者没有参与研究设计、数据收集/分析/解释、手稿撰写或决定将文章提交发表。
{"title":"Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy”","authors":"Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen","doi":"10.1016/j.jhep.2024.10.041","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.041","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>AUTHOR CONTRIBUTIONS</h2>RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.</section></section><section><section><h2>DISCLOSURES/ CONFLICT OF INTEREST STATEMENT</h2>MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.</section></section><section><section><h2>DATA AVAILABILITY STATEMENT</h2>The data from this study is available from the corresponding author upon reasonable request.</section></section><section><section><h2>Funding</h2>Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"61 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma exchange in Acute liver failure: The jury is still out! 急性肝衰竭的血浆置换:尚无定论!
IF 25.7 2区 生物学 Q1 BIOCHEMICAL RESEARCH METHODS Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.037
Sagnik Biswas, Shekhar Swaroop

Section snippets

Financial disclosures funding

None

Conflicts of interest COI

The authors declare no conflicts of interest

Authors contributions author-disclosure

SB and SS wrote the initial draft. S revised the paper. All authors approved the final manuscript.
章节片段财务披露资金无利益冲突作者声明无利益冲突作者供稿作者披露SB和SS撰写了初稿。S 修改了论文。所有作者都批准了最终稿。
{"title":"Plasma exchange in Acute liver failure: The jury is still out!","authors":"Sagnik Biswas, Shekhar Swaroop","doi":"10.1016/j.jhep.2024.10.037","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.037","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial disclosures funding</h2>None</section></section><section><section><h2>Conflicts of interest COI</h2>The authors declare no conflicts of interest</section></section><section><section><h2>Authors contributions author-disclosure</h2>SB and SS wrote the initial draft. S revised the paper. All authors approved the final manuscript.</section></section>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"45 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ACS Synthetic Biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1